Andy Horowitz is a leader and entrepreneur in the post-acute healthcare industry. An attorney by education, he has founded several regional and national companies. In 2006, he founded hospice specialty pharmacy provider Enclara Health. In 2013, Andy founded Turn-Key Health as a subsidiary of Enclara Health focused on solving the problem of poor quality, low satisfaction and extreme high cost during the last years of life.
In 2014 Andy created Enclara Healthcare and partnered with Consonance Capital Partners to purchase and combine excelleRx/Hospice Pharmacia with Enclara Health to create Enclara Pharmacia, which now serves over a third of the hospice through comprehensive mail order and local pharmacy offerings, digital solutions and clinical support. The deal also included PBM Plus, which was integrated into Enclara Healthcare to create GuidantRx, a boutique pharmacy benefit management provider specializing in self-insured employer pharmacy benefits management and co-pay card services. Enclara Healthcare would grow to be leading solutions provider focused on simplifying care delivery in complex care populations to improve patient experience, quality and cost.
In 2020, Andy, together with Consonance Capital Partners, sold Enclara Healthcare, including Enclara Pharmacia and GuidantRx, to Humana. Turn-Key Health was sold in a separate transaction to CareCentrix. Andy led Enclara Healthcare through a successful transition period before stepping down as CEO in September 2020. He remains affiliated with Enclara as a special advisor to the executive team.
Prior to founding Enclara, Andy founded Partners Healthcare, which focused on the institutional long-term care pharmacy market, and Solutions Homecare, a JCAHO-accredited infusion therapy company. He also acquired a New Jersey based hospice business known as Garden State Hospice and, after rebranding as Care Alternatives, developed it into a large, regional hospice services company providing care to approximately 800 patients per day. Between 1998 and 2004, Andy grew these companies into one of the largest privately held institutional pharmacies and hospices in the country, serving six states, until he sold the combined business in 2004.